HKEX: 6855 - Ascentage Pharma Group International

Yield per half year: +94.71%
Sector: Healthcare

Current price
38.8 HK$
Average price
30.51 HK$ -21.37%

Price based on EPS
45.38 HK$ +16.96%
Discount price Net Income
15.63 HK$ -59.71%
5/10

Price based on EPS

Price = Price * (100 - CAGR EPS * Excess Key Rate) / 100
Key Rate = Key rate
Fair price = 45.38 HK$
Current price = 38.8 HK$ (difference = +16.96%)


Data

Discounted Cash Flow (Based EBITDA)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount Ebitda(5) * (1 + Ebitda Yield) / (WACC - Ebitda Yield)
Company Value = ∑ (Future Ebitda / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = -60.44 HK$
Current price = 38.8 HK$ (difference = -255.77%)


Data

Discounted Cash Flow (Based FCF)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount FCF(5) * (1 + FCF Yield) / (WACC - FCF Yield) ^ 5
Company Value = ∑ (FCF / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = -198.25 HK$
Current price = 38.8 HK$ (difference = -610.95%)


Data

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription